0001209191-23-001757.txt : 20230105
0001209191-23-001757.hdr.sgml : 20230105
20230105160036
ACCESSION NUMBER: 0001209191-23-001757
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230104
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oestreich Stephanie
CENTRAL INDEX KEY: 0001901450
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39655
FILM NUMBER: 23511189
MAIL ADDRESS:
STREET 1: 75 STATE STREET, SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galecto, Inc.
CENTRAL INDEX KEY: 0001800315
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371957007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 45-70-70-52-10
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto Inc.
DATE OF NAME CHANGE: 20200116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-04
0
0001800315
Galecto, Inc.
GLTO
0001901450
Oestreich Stephanie
C/O GALECTO, INC.
OLE MAALOES VEJ 3
OLE MAALOES VEJ 3
G7
DK-2200
DENMARK
0
1
0
0
Chief Business Officer
Stock Option (right to buy)
1.21
2023-01-04
4
A
0
80000
0.00
A
2033-01-03
Common Stock
80000
80000
D
25% of the shares subject to such option vested and became exercisable on January 4, 2024 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Garrett Winslow, Attorney-in-fact
2023-01-05